Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Argus Health
Johnson and Johnson
Daiichi Sankyo

Generated: October 21, 2017

DrugPatentWatch Database Preview

NEO-MEDROL Drug Profile

« Back to Dashboard

What is the patent landscape for Neo-medrol, and what generic Neo-medrol alternatives are available?

Neo-medrol is a drug marketed by Pharmacia And Upjohn and is included in two NDAs.

The generic ingredient in NEO-MEDROL is methylprednisolone acetate; neomycin sulfate. There are forty drug master file entries for this compound. Additional details are available on the methylprednisolone acetate; neomycin sulfate profile page.

Summary for Tradename: NEO-MEDROL

US Patents:0
Clinical Trials: see list326
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:NEO-MEDROL at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn
methylprednisolone; neomycin sulfate
OINTMENT;OPHTHALMIC060645-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
methylprednisolone acetate; neomycin sulfate
CREAM;TOPICAL060611-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
methylprednisolone acetate; neomycin sulfate
CREAM;TOPICAL060611-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Federal Trade Commission
Boehringer Ingelheim
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus